Recently, CMC Clinical Research Base was completed in Taizhou TCM-Integrated Hospital. It is so far the largest clinical trial base in China, with more than 200 beds. It provides specialized services such as phase I clinical trials of new drugs, quality consistency evaluation of generic drugs and clinical trials of medical devices. The completion of the base fills a gap in CMC's industrial chain.
In the future, the base will continue to build high-end platforms and expand services based on the existing offerings and strive to extend its reach to Phase II and Phase III clinical trials within five years, providing solid support for CMC to establish a closed-loop whole industrial chain ecosystem and realize high-quality development, and promoting innovative drug R&D in China.